TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Clinical trials for TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT trials appear
Sign up with your email to follow new studies for TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in major diabetes and weight loss trial
Disease control OngoingThis study is testing whether a new injectable medication called maridebart cafraglutide helps adults with type 2 diabetes lose weight. Over 1,100 participants who are overweight or have obesity will receive either the drug or a placebo for 72 weeks. The main goal is to see if th…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC
-
Handheld scanners and monitors aim to catch chronic diseases early
Diagnosis ENROLLING_BY_INVITATIONThis study tests whether portable devices like handheld ultrasound and blood glucose monitors can help doctors find chronic diseases earlier than standard care. Two hundred adults aged 18 to 75 with conditions like prediabetes or high blood pressure will use the devices or receiv…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Phase: EARLY_PHASE1 • Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated May 07, 2026 18:43 UTC